INSIDERFilingvia Quantisnow
PMV Pharmaceuticals Inc. logo

PMV Pharmaceuticals (PMVP) director Flowers received 67,500 Stock Option (right to buy)

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Kirsten Flowers (director at PMV Pharmaceuticals Inc., PMVP) reported that they received 67,500 Stock Option (right to buy) on Jun 6, 2024.

Reporting person
Flowers Kirsten

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 6, 2024Grant or award (A)Stock Option (right to buy)On 67,500 Common Stock1+67,500--67,500 direct

Holdings before and after

  • Stock Option (right to buy): 0 to 67,500 direct

Footnotes from the filing

  1. 1. The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Flowers report in this PMVP Form 4?

Kirsten Flowers (director at PMV Pharmaceuticals Inc., PMVP) reported that they received 67,500 Stock Option (right to buy) on Jun 6, 2024.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for PMVP

Earlier insider filings at PMVP

Quantisnow market dataNASDAQ
PMV Pharmaceuticals Inc. logo
PMVP
PMV Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2020
Get push alerts for PMVP

Follow PMVP and get a push notification the moment its next story breaks.

Full PMVP profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PMVP (PMV Pharmaceuticals Inc.) and more on Quantisnow.